Richard D. Brounstein serves as Executive at CALYPTE BIOMEDICAL CORP, where they oversee executive responsibilities. Since joining the company, Richard D. Brounstein has executed 5 insider transactions totaling $46.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 21, 2021 involved purchasing 5,000 shares valued at $16.9K.
Richard D. Brounstein currently holds 102,075 shares of CALYPTE BIOMEDICAL CORP (CBMC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard D. Brounstein has been a net buyer of CBMC stock. They have purchased $46.8K and sold $0 worth of shares.
Richard D. Brounstein's most recent insider trade was on Dec 21, 2021, when they purchased 5,000 shares at $3.37 per share.
Get notified when new Form 4 filings are submitted
| $5.99 |
| Discretionary |
| Nov 11, 2021 | BEAT | $40.9K | Option Exercise | 9,732 | $4.20 | Discretionary |
| Nov 11, 2021 | BEAT | $81.8K | Option Exercise | 19,465 | $4.20 | Discretionary |
| Mar 28, 2007 | CBMC | $192.3K | Other | 3,846,154 | $0.05 | Discretionary |